PIONEERING THE NEXT GENERATION
OF TARGETED PSYCHOACTIVE MEDICATIONS
TSXV: PSYB
Platform Technology Utilizing Metabolic Engineering and Optimization Techniques
Developing an efficient, patent-pending bacterial biosynthesis process for tryptamine production
Metabolic Engineering to Advance the Standard of Care
Targeted Treatment: Variation in hallucinogenic efficacy of Psilocybe mushrooms is likely due to variation in the relative concentration of these compounds
Industry Comparables
The antidepressant drug market was valued at USD 13.39 billion in 2018 and expected to reach USD 15.88 billion by 2025
